Mutational and expression analysis of the p73 gene in melanoma cell lines

Cancer Research

Volumn 59, Issue 1, 1999, Pages 172-174

  Tsao, Hensin ^a   Zhang, Xue ^a,b   Majewski, Paul ^a   Haluska, Frank G ^a,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b CHINA MEDICAL UNIVERSITY   (China)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P21; PROTEIN P53;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CHROMOSOME MAP; DNA SEQUENCE; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

CHROMOSOME MAPPING; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MELANOMA; NUCLEAR PROTEINS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0032953808     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Albino, A. P., and Fountain, J. W. Molecular genetics of malignant melanoma. In: L. Nathanson (ed.) Current Research and Clinical Management of Melanoma, pp. 201-255. Norwell, MA: Kluwer Academic Publishers, 1993.
2. Thompson, F. H., Emerson, J., Olson, S., Weinstein, R., Leavitt, S. A., Leong, S. P. L., Emerson, S., Trent, J. M., Nelson, M. A., Salmon, S. E., and Taetle, R Cytogenetics of 158 patients with regional or disseminated melanoma. Cancer Genet. Cytogenet., 83: 93-104, 1995.
3. Dracopoli, N. C., Harnett, P., Bale, S. J., Stanger, B. Z., Tucker, M. A., Housman, D. E., and Kefford, R. F. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc. Natl. Acad. Sci. USA, 86: 4614-4618, 1989.
4. Bale, S. J., Dracopoli, N. C., Tucker, M. A., Clark, W. H., Jr., Fraser, M. C., Stanger, B. Z., Green, P., Donis-Keller, H., Housman, D. E., and Greene, M. H. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus syndrome to chromosome 1p. N. Engl. J. Med., 320: 1367-1372, 1989.
5. Goldstein, A. M., Dracopoli, N. C., Ho, E. C., Fraser, M. C., Keams, K. S., Bale, S. J., McBride, O. W., Clark, W. H., Jr., and Tucker, M. A. Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p and evidence for genetic heterogeneity. Am. J. Hum. Genet., 52: 537-550, 1993.
6. Goldstein, A. M., Goldin, L. R., Dracopoli, N. C., Clark, W. H. J., and Tucker, M. A. Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi. Am. J. Hum. Genet., 58: 1050-1056, 1996.
7. Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Jr., Tucker, M. A., and Dracopoli, N. C. Germline p16 mutations in familial melanoma. Nat. Genet., 8: 15-21, 1994.
8. Brodeur, G. M., Green, A. A., Hayes, F. A., Williams, K. J., Williams, D. L., and Tsiatis, A. A. Cytogenetic features of human neuroblastomas and cell lines. Cancer Res., 41: 4678-4686, 1981.
9. Gilbert, F., Balaban, G., Moorhead, P., Bianchi, D., and Schlesinger, H. Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines. Cancer Genet. Cytogenet., 7: 33-42, 1982.
10. Thompson, F. H., Taetle, R., Trent, J. M., Liu, Y., Massey-Brown, K., Scott, K. M., Weinstein, R. S., Emerson, J. C., Alberts, D. S., and Nelson, M. A. Band 1p36 abnormalities and t(1;17) in ovarian carcinoma. Cancer Genet. Cytogenet., 96: 106-110, 1997
11. Nagai, H., Negrini, M., Carter, S. L., Gillum, D. R., Rosenberg, A. L., Schwatrz, G. F., and Croce, C. M. Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer. Cancer Res., 55: 1752-1757, 1995.
12. Lothe, R. A., Andersen, S. N., Hofstad, B., Meling, G. I., Peltomaki, P., Heim, S., Brogger, A., Vatn, M., Rognum, T. O., and Borresen, A. L. Deletion of 1p loci and microsatellite instability in coloreclal polyps. Genes Chromosomes Cancer, 14: 182-188, 1995.
13. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J. C., Valent, A., Minty, A., Chalon, P., Lelias, J. M., Dumont, X., Ferrara, P., McKeon, F., and Caput, D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90: 809-819, 1997.
14. Lubbe, J., Reichel, M., Burg, G., and Kleihues, P. Absence of p53 gene mutations in cutaneous melanoma. J. Invest. Dermatol., 102: 819-821, 1994.
15. Albino, A. P., Vidal, M. J., McNutt, N. S., Shea, C. R., Prieto, V. G., Nanus, D. M., Palmer, J. M., and Hayward, N. K. Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res., 4: 35-45, 1994.
16. Poremba, C., Yandell, D. W., Metze, D., Kamanabrou, D., Bocker, W., and Dockhorn-Dworniczak, B. Immunohistochemical detection of p53 in melanomas with rare p53 gene mutations is associated with mdm-2 overexpression. Oncol. Res., 7: 331-339, 1995.
17. Castresana, J. S., Rubio, M. P., Vasquez, J. J., Idoate, M., Sober, A. J., Seizinger, B. R., and Barnhill, R. L. Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma. Int. J. Cancer, 55: 562-565, 1993.
18. INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. Cancer Res., 56: 5023-5032, 1996.
19. Tsao, H., Benoit, E., Sober, A. J., Thiele, C., and Haluska, F. G. Novel mutations in the p16/CDKN2A binding region of the cyclin-dependent kinase-4 (CDK4) gene. Cancer Res., 58: 109-113, 1997.
20. Vance, J. M., Matise, T. C., Wooster, R., Schutte, B. C., Bruns, G. A., van Roy, N., Brodeur, G. M., Tao, Y. X., Gregory, S., Weith, A., Vaudin, M., and White, P. Report and abstracts of the third international workshop on human chromosome 1 mapping 1997. Cytogenet. Cell Genet., 78: 154-182, 1997.
21. Walker, G. J., Palmer, J. M., Walters, M. K., and Hayward, N. K. A genetic model of melanoma tumorigenesis based on allele losses. Genes Chromosome Cancer, 12: 134-141, 1995.
22. White, P. S., Maris, J. M., Beltinger, C., Sulman, E., Marshall, H. N., Fujimori, M., Kaufman, B. A., Biegel, J. A., Allen, C., Hilliard, C., Valentine, M. B., Look, A. T., Enomoto, H., Sakiyama, S., and Brodeur, G. M. A region of consistent deletion in neuroblastoma maps within human chromosome lp36.2-36.3. Proc. Natl. Acad. Sci. USA, 92: 5520-5524, 1995.
23. Nomoto, S., Haruki, N., Kondo, M., Konishi, H., Takahashi, T., Takahashi, T., and Takahashi, T. Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res., 58: 1380-1383, 1998.
24. Takahashi, H., Ichimiya, S., Nimura, Y., Watanabe, M., Furusato, M., Wakui, S., Yatani, R., Aizawa, S., and Nakagawara, A. Mutation, allelotyping, and transcriptional analyses of the p73 gene in prostatic carcinoma. Cancer Res., 58: 2076-2077, 1998.
25. Versteeg, R., Caron, H., Cheng, N. C., van der Drift, P., Slater, R., Westerveld, A , Voute, P. A., Delattre, O., Laureys, G., Van Roy, N., and Speleman, F. 1p36: every subband a tumor suppressor? Eur. J. Cancer, 31A: 538-541, 1995.
26. Mai, M., Yokomizo, A., Qian, C., Yang, P., Tindall, D. J., Smith, D. I., and Liu, W. Activation of p73 silent allele in lung cancer. Cancer Res., 58: 2347-2349, 1998.